Structure activity relationships of stendomycin, a lipopeptide antibiotic from Streptomyces
Losilla, B.; Pommier, M.T.; Bonnaveiro, N.; Cremieux, A.; Michel, G.
Microbios 71(286): 75-80
1992
ISSN/ISBN: 0026-2633 PMID: 1406345 Document Number: 391355
A strain of Streptomyces which produced stendomycin, a lipopeptide antibiotic, was grown in culture media containing various amino acids as nitrogen substrates. The nature of the fatty acid component of stendomycin was dependent on the nature of the amino acid present in the medium, but this did not affect antibiotic activity. Modifications in the peptide moiety resulted in a loss of antifungal activity.
Document emailed within 1 workday
Related Documents
Eliopoulos, G.M.; Willey, S.; Reiszner, E.; Spitzer, P.G.; Caputo, G.; Moellering, R.C. 1986: In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic Antimicrobial Agents and Chemotherapy 30(4): 532-535Terlain, B.; Thomas, J.P. 1971: Structure of griselimycin, polypeptide antibiotic extracted Streptomyces cultures. I. Identification of the products liberated by hydrolysis Bulletin de la Societe Chimique de France (6): 2349-2356
Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Ivanova, I.V.; Khristova, K.G.; Tishkov, S.K.; Moncheva, P.A. 1992: Effect of protoplasting on antibiotic activity and resistance in the strain Streptomyces hygroscopicus 155 Antibiotiki i Khimioterapiia 37(11): 3-5
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91
Jönsson, N.A. 1972: Chemical structure and teratogenic properties. 3. a review of available data on structure-activity relationships and mechanism of action of thalidomide analogues Acta Pharmaceutica Suecica 9(6): 521-542
Delle Monache, F.; Marini-Bettòlo, G.B.; Leoncio de Albuquerque, I.; De Andrade Lyra, F.D.; Gonçalves da Lima, O. 1970: Chemical composition of retamycin, an antibiotic complex with anti-tumor activity produced by Streptomyces olidensis nov.sp.(IAUFPe 5622) Annali Dell'istituto Superiore di Sanita 6(6): 357-364
Altomare, C.; Carotti, A.; Cellamare, S.; Carrieri, A.; Ciabatti, R.; Malabarba, A. 1994: Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships Journal of Pharmacy and Pharmacology 46(12): 994-999
Stanković, S. 2001: X-rays in molecular biophysics: structure-activity relationships and activity of steroid hormones Medicinski Pregled 54(9-10): 413-421
Cechinel Filho, V.; Pinheiro, T.; Nunes, R.J.; Yunes, R.A.; Cruz, A.B.; Moretto, E. 1994: Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships Farmaco 49(10): 675-677
Richards, R.K. 1980: Structure-activity relationships in the effects of phenacemide analogs on serum creatinine and anticonvulsant activity Archives Internationales de Pharmacodynamie et de Therapie 244(1): 107-112
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018
Rosenkranz, H.S.; Frierson, M.R.; Klopman, G. 1986: Use of structure-activity relationships in predicting carcinogenesis Iarc Scientific Publications 1986(83): 497-517
Mager, P.P. 1983: Structure-activity relationships of dermorphin tetrapeptide amides Die Pharmazie 38(8): 563
Barth, A.; Franke, R. 1975: Quantitative structure-activity relationships in phytotoxic piperidinoacetanilides Environmental Quality and Safety. Supplement 3: 467-472
Bercher, H.; Grisk, A. 1976: Structure-activity relationships of halogenated phenylethanolamine and phenoxypropanolamine Acta Biologica et Medica Germanica 35(1): 79-85
Rietschel, E.T.; Seydel, U.; Zähringer, U.; Schade, U.F.; Brade, L.; Loppnow, H.; Feist, W.; Wang, M.H.; Ulmer, A.J.; Flad, H.D. 1991: Bacterial endotoxin: molecular relationships between structure and activity Infectious Disease Clinics of North America 5(4): 753-779
Bowden, K.; Harris, N.V.; Watson, C.A. 1993: Structure-activity relationships of dihydrofolate reductase inhibitors Journal of ChemoTherapy 5(6): 377-388
Beránek, J. 1986: A study on structure-activity relationships of nucleoside analogues Drugs under Experimental and Clinical Research 12(4): 355-367
Lattrell, R.; Dürckheimer, W.; Kirrstetter, R.; Limbert, M.; Seibert, G. 1987: Structure-activity relationships in the cefpirome (HR 810) series: synthesis and antibacterial activity of 7 alpha-methoxy and 7 alpha-formylamino analogues of HR 810 Chemioterapia: international journal of the Mediterranean Society of Chemotherapy 6(2 Suppl): 96-97